Waltham, MA, United States of America

Michael Steven Curtis

USPTO Granted Patents = 4 


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Glorieta, NM (US) (1990)
  • Waltham, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 1990-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Michael Steven Curtis

Introduction

Michael Steven Curtis, based in Waltham, MA, is a notable inventor with a focus on innovations in the field of biotechnology. With a total of four patents to his name, Curtis has contributed significantly to methods that involve treating complement mediated diseases through sophisticated protein constructs.

Latest Patents

Curtis's latest patents illustrate his expertise and commitment to advancing medical treatments. One of his prominent patents involves "Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator." This patent describes fusion protein constructs designed to bind a complement-associated antigen, which includes a targeting moiety and a complement modulator protein. The constructs aim to provide effective means for treating conditions arising from complement mediation.

Another key patent is titled "Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide." Similar to the previous one, this invention presents constructs that can bind to complement-associated antigens, enhancing therapeutic approaches in dealing with complement mediation conditions. These innovations reflect Curtis's dedication to improving healthcare outcomes.

Career Highlights

Throughout his career, Curtis has been associated with key organizations like Q32 Bio Inc., where he has applied his expertise in biotechnology and patent development. His contributions to the field are underscored by the advancements brought forward by his patents.

Collaborations

Michael Steven Curtis has collaborated with remarkable individuals, including Michael Storek and Shelia Marie Violette. Through these partnerships, Curtis has been able to merge his innovative ideas with the expertise of others, fostering a collaborative environment that sparks new advancements.

Conclusion

Michael Steven Curtis stands out as a significant figure in the realm of biotechnology inventions. His innovative patents not only contribute to the scientific community but also hold the potential to enhance patient care and treatment options for complement mediated diseases. With his ongoing work, Curtis continues to pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…